Hagen von Briesen - Concepedia

Author

Hagen von Briesen

Fraunhofer Institute for Biomedical Engineering ORCID

Also Known As

Briesen, Hagen Von, H von Briesen, H. Briesen, H. V. Briesen, H. VON BRIESEN, H. Von Briesen, H. v. Briesen, H. von Briesen, H.V. Briesen, H.Von Briesen

174

Publications

8.4K

Citations

H-Index

176

Concepts

All Affiliations

Fraunhofer Institute for Biomedical Engineering Georg Speyer Haus Goethe University Frankfurt Saarland University University of Münster

About

Hagen von Briesen is an author at Fraunhofer Institute for Biomedical Engineering specializing in medicine, engineering, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	56	3.4K
2	Engineering	24	33	3.2K
3	Natural Sciences	5	5	434
4	Health Sciences	3	3	99
5	Public Health	3	3	173

Hagen von Briesen

105

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Optimization of the preparation process for human serum albumin (HSA) nanoparticles Klaus Langer, Sabine Balthasar, Vitali Vogel, International Journal of Pharmaceutics NanoparticlesEngineeringProtein NanoparticlesNanomaterialsNanobiotechnology	2003	739
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles Jörg Kreuter, Peter Ramge, Stefan Hamm, Pharmaceutical Research	2003	464
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones Anja Zensi, David J. Begley, Charles Pontikis, Journal of Controlled Release NanomedicineEngineeringApo ENano-drug DeliveryNeuroscience	2009	426
Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in China Ling Su, Marcus Graf, Yuanzhi Zhang, Journal of Virology Molecular Epidemiology StudyGeneticsImmunologyGenomicsPhylogenetic Analysis	2000	297
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization Feng Gao, Sandra G. Morrison, D L Robertson, Journal of Virology GeneticsSubtype B VirusesImmunologyMolecular BiologyHiv-1 Isolates	1996	286
Multi-endpoint toxicological assessment of polystyrene nano- and microparticles in different biological models in vitro Michelle Hesler, Leonie Aengenheister, Bernhard Ellinger, Toxicology in Vitro	2019	270
Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model Sylvia Wagner, Anja Zensi, Sascha Wien, PLoS ONE	2012	252
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes Norbert Dinauer, Sabine Balthasar, Carolin Weber, Biomaterials NanoparticlesNanomedicinePrimary T-lymphocytesEngineeringAntibody-conjugated Nanoparticles	2005	229
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes Sabine Balthasar, Kerstin Michaelis, Norbert Dinauer, Biomaterials NanoparticlesNanomedicineDrug Carrier SystemEngineeringImmunology	2004	222
Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells Peter Ramge, Ronald E. Unger, Jens B. Oltrogge, European Journal of Neuroscience	2000	195

Page 1